Evofem Biosciences, Inc. (EVFM)

Evofem Biosciences Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar 25, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Market Capitalization	1	1	1	1	8	61
Market Cap Growth	27.41%	7.24%	-12.38%	-83.76%	-87.13%	-68.73%
Enterprise Value	60	58	50	44	114	149
Last Close Price	0.01	0.01	0.01	0.06	8.00	704.06
PE Ratio	23.88	4.39	-	0.03	-	-
PS Ratio	0.06	0.06	0.06	0.07	0.47	7.43
PB Ratio	-0.02	-0.02	-0.02	-0.02	-0.11	-0.61
EV/Sales Ratio	2.99	2.88	2.61	2.43	6.76	18.08
EV/EBITDA Ratio	28.86	29.70	-	-	-	-
EV/EBIT Ratio	42.00	40.39	-	-	-	-
Debt / Equity Ratio	-0.79	-0.79	-0.69	-0.70	-0.99	-1.16
Debt / EBITDA Ratio	26.05	26.05	-	-	-	-
Net Debt / Equity Ratio	-0.78	-0.78	-0.69	-0.70	-0.95	-1.08
Net Debt / EBITDA Ratio	27.81	27.81	-6.52	-2.49	-0.82	-0.65
Net Debt / FCF Ratio	-27.25	-27.25	-11.76	-4.83	-0.97	-0.72
Asset Turnover	0.92	0.92	1.13	1.02	0.50	0.11
Inventory Turnover	3.41	3.41	2.34	1.84	0.68	0.55
Quick Ratio	0.15	0.15	0.12	0.08	0.04	0.10
Current Ratio	0.18	0.18	0.17	0.13	0.14	0.22
Return on Assets (ROA)	4.08%	4.08%	-27.94%	-62.46%	-155.38%	-136.74%
Return on Invested Capital (ROIC)	-	-	-	-	-3409.97%	-713.28%
Return on Capital Employed (ROCE)	-2.20%	-2.20%	13.50%	28.80%	122.50%	175.30%
Earnings Yield	24.32%	32.49%	-789.50%	4136.67%	-972.56%	-334.95%
FCF Yield	-177.27%	-165.93%	-347.43%	-700.55%	-897.15%	-244.21%
Buyback Yield / Dilution	-7926.85%	-7926.85%	91.87%	-211082.03%	-567.40%	-94.93%

Source: S&P Global Market Intelligence. Standard template. Financial Sources.